MedTrace Logo

AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA

NCT01656967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2018-11-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare two types of supraglottic airways (SGA), the Ambu® Aura-I and the Intubating Laryngeal Mask Airway (ILMA), regarding time to intubate, ease of insertion, sealing properties, optical view upon fiberoptic examination regarding the Ambu Aura-I, ease and success rate of intubation, airway morbidity, and patient comfort in patients undergoing general anesthesia for elective surgery.

Conditions

  • Supraglottic Airway

Interventions

DEVICE

AMBU Aura-I/aScope 2

Once ventilation is achieved, the patients in group A will be intubated through the shaft of Aura-I via the the Ambu aScope.

DEVICE

LMA Fastrach Single Use

The patients in group B will be intubated by ETT via the Intubating LMA as is standard procedure.

Sponsors & Collaborators

  • Ambu A/S

    collaborator INDUSTRY

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Carin A Hagberg, MD · The University of Texas Medical School at Houston

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01656967 on ClinicalTrials.gov